Editorial
Published on 04 Apr 2025
Editorial: Allergies and anti-allergy drug discovery in Africa
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2025.1593023
- 511 views
Type at least 3 characters
620 articles
Mini Review
Published on 03 Apr 2025
Cure for the itch: current clinical standards and therapies in allergic eczema
in Skin Allergy
Frontiers in Allergy
doi 10.3389/falgy.2025.1569292
- 912 views
Brief Research Report
Published on 03 Apr 2025
Development and validation of a Delphi consensus-based questionnaire for the multidisciplinary management of type 2 inflammation-related diseases
in Allergy Diagnosis
Frontiers in Allergy
doi 10.3389/falgy.2025.1543504
- 1,223 views
Review
Published on 31 Mar 2025
How does asthma coexistence affect the strategic selection of biologic therapies in CRSwNP management?
in Rhinology
Frontiers in Allergy
doi 10.3389/falgy.2025.1579224
- 1,181 views
Original Research
Published on 31 Mar 2025
Fire ant-venom anaphylaxis prevalence in the general population and patients with systemic mastocytosis
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2025.1570123
- 1,009 views
Review
Published on 31 Mar 2025
Breaking the cycle: a comprehensive exploration of topical steroid addiction and withdrawal
in Skin Allergy
Frontiers in Allergy
doi 10.3389/falgy.2025.1547923
- 3,558 views
Mini Review
Published on 28 Mar 2025
In vitro models to study viral-induced asthma exacerbation: a short review for a key issue
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1530122
- 599 views
Hypothesis and Theory
Published on 27 Mar 2025
The Acari Hypothesis, VII: accounting for the comorbidity of allergy with other contemporary medical conditions, especially metabolic syndrome
in Infections and Microbiome
Frontiers in Allergy
doi 10.3389/falgy.2025.1537467
- 1,110 views
Brief Research Report
Published on 27 Mar 2025
Basophil activation test and lymphocyte transformation test in cefuroxime-induced anaphylactic reactions
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2025.1532775
- 690 views
Original Research
Published on 21 Mar 2025
Association between vaccination, viral antibodies, and asthma prevalence in the U.S.: insights from NHANES (1999–2020)
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1456934
- 1,301 views
Study Protocol
Published on 21 Mar 2025
Study protocol for a randomized double-blinded placebo-controlled trial on mepolizumab for patients with chronic rhinosinusitis with nasal polyps, NSAID exacerbated respiratory disease and asthma
in Rhinology
Frontiers in Allergy
doi 10.3389/falgy.2025.1568081
- 1,126 views
Correction
Published on 20 Mar 2025
Corrigendum: Gut microbiome features in pediatric food allergy: a scoping review
in Food Allergy
Frontiers in Allergy
doi 10.3389/falgy.2025.1588779
- 570 views
Original Research
Published on 20 Mar 2025
Durability of benralizumab effectiveness in severe eosinophilic asthma patients with and without chronic rhinosinusitis with nasal polyps: a post hoc analysis from the ANANKE study
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1501196
- 1,181 views
Original Research
Published on 20 Mar 2025
Respiratory symptoms, sensitisation and occupational exposure in the shrimp processing industry
in Environmental & Occupational Determinants
Frontiers in Allergy
doi 10.3389/falgy.2025.1520576
- 911 views
Original Research
Published on 19 Mar 2025
Food allergen introduction practices and parent/caregiver attitudes based on family history of food allergy
in Food Allergy
Frontiers in Allergy
doi 10.3389/falgy.2025.1562667
- 840 views
Methods
Accepted on 17 Mar 2025
Multiplex IgE peanut panels: critical appraisal of assay designs and the overall good, the bad and the ugly features of the applied allergen components
in Allergy Diagnosis
Frontiers in Allergy
doi 10.3389/falgy.2025.1515294
- 170 views